Barbexaclone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Barbexaclone
Barbexaclone.png
Combination of
Phenobarbital Barbiturate
Propylhexedrine Stimulant (sympathomimetic)
Clinical data
AHFS/Drugs.com International Drug Names
Legal status ?
Identifiers
CAS number 4388-82-3
ATC code N03AA04
PubChem CID 71196
ChemSpider 64332 YesY
UNII 291GX1YB65 YesY
 YesY (what is this?)  (verify)

Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine. It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results" had not yet been confirmed nor denied in controlled trials. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.

Recreational use recreational users of this drug report a feeling of emphatogenity, reductıon of social inhibition and a relaxation. This might be due to the combination of an stimulant and a depressant such as Methamphetamine and GHB while the latter is much more powerful

References[edit]

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. p. 472. ISBN 0-632-06046-8